Octagon Therapeutics
Health Care · Immunology & Inflammation Therapeutics
$11.4Mtotal raised · 4 rounds on record
$11Mlatest round · Venture round · Jan 2024 · 2 yr ago
1backers · Walnut Venture Associates
10+team · employees, estimated range
Overview
A biotech company developing better medicines for patients with autoimmune and inflammatory diseases. Leveraging powerful insights into the glycoproteome.
Funding and backers
Total raised
$11.4M
4 rounds on record
Latest round
$11M
Venture round · Jan 2024 · 2 yr ago
Team
11-50
employees, estimated range
Backers
1
Walnut Venture Associates
The money's age
Long since its last round
33 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 29, 2024
Raised a round Venture round $11M · SEC Form D
Jun 1, 2020
Raised a round Convertible Note $398k · SEC Form D
Nov 15, 2019
Took on debt financing $511k · SEC Form D
Oct 15, 2018
Took on debt financing $538k · SEC Form D
2016
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jan 2024 | $11M | — | SEC Form D |
| Convertible Note | Jun 2020 | $398k | — | SEC Form D |
| Debt Financing | Nov 2019 | $511k | — | SEC Form D |
| Debt Financing | Oct 2018 | $538k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Octagon Therapeutics, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Fred AusubelExecutive Officer, DirectorSEC Form D
Isaac StonerExecutive Officer, DirectorSEC Form D
Shen YuExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Unlocking evolutionary biology by translating nature’s molecules into medicines for patients with cancer and inflammatory diseases.
Boomerang Medical is a bioelectronic medicine company targeting autoimmune diseases.
Quell Therapeutics is a clinical-stage company, fuelled by curiosity and discovery, on a mission to make life better for those battling…
Coultreon Biopharma is a clinical-stage biotech company developing next-generation precision medicines for immunology and autoimmune…
Company Management Team Board of Directors Scientific Advisory Board Clinical Advisory Board Company History Investors Science Biology…
We believe that clinical remission should be the standard—not the exception—for treating chronic inflammatory diseases like COPD, asthma…
People
Fred Ausubel
Executive Officer, Director
Isaac Stoner
Executive Officer, Director
Shen Yu
Executive Officer, Director
Paul Goldenheim
Director
Thorne Sparkman
Director
Ronald Lennox
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Walnut Venture AssociatesVia a fund
93 portfolio companies: Bigtincan, Konovo, E-Mail-Sicherheit und GRC - Made in Germany - and 90 more
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Allston
United States
HQ
10-50 est. staff